Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

INTRODUCTION: COVID-19 cases are on surge; however, there is no efficient treatment or vaccine that can be used for its management. Numerous clinical trials are being reviewed for use of different drugs, biologics, and vaccines in COVID-19. A much empirical approach will be to repurpose existing dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Harpinder, Shekhar, Nishant, Sharma, Saurabh, Sarma, Phulen, Prakash, Ajay, Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778723/
https://www.ncbi.nlm.nih.gov/pubmed/33389725
http://dx.doi.org/10.1007/s43440-020-00195-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778723/
https://www.ncbi.nlm.nih.gov/pubmed/33389725
http://dx.doi.org/10.1007/s43440-020-00195-y

Ejemplares similares